Early detection of gynecological malignancies is vital for patient management and prolonging the patient’s survival. Molecular imaging, such as positron emission tomography (PET)/computed tomography, has been increasingly utilized in gynecological… Click to show full abstract
Early detection of gynecological malignancies is vital for patient management and prolonging the patient’s survival. Molecular imaging, such as positron emission tomography (PET)/computed tomography, has been increasingly utilized in gynecological malignancies. PET/magnetic resonance imaging (MRI) enables the assessment of gynecological malignancies by combining the metabolic information of PET with the anatomical and functional information from MRI. This article will review the updated applications of PET/MRI in gynecological malignancies.
               
Click one of the above tabs to view related content.